TMCnet News
Nortech Systems Announces 2022 First Quarter ResultsNortech Systems Incorporated (Nasdaq: NSYS), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical, defense and industrial markets, reported results for the first quarter ended March 31, 2022. 2022 First Quarter Highlights
Management Commentary "We were pleased to begin 2022 with continuing positive momentum from last year and we are optimistic about the remainder of this year," said Jay D. Miller, Chief Executive Officer and President. "In partnership with our customers and suppliers, everyone at Nortech worked diligently to help mitigate ongoing supply chain challenges, inflationary pressures, and lingering pandemic impacts. "Our team made significant progress in several key performance areas during the quarter, including revenue growth, pricing adjustments, operating cash flow, and new product development," noted Mr. Miller. Launched last month, Nortech's Active Optical Xtreme (AOX) cable technologies target challenging data-dependent applications - including factory automation, machine vision and robotics - and complement the Company's Intercon 1 product line. Mr. Miller added, "Developing select proprietary technologies complements our global manufacturing operations and engineering services." 2022 First Quarter Results (in thousands)
In the first quarter of 2022, revenue totaled $30.7 million. This represents a 39.1% increase from revenue of $22.1 million in the first quarter of 2021. Net income totaled $138,000, or $0.05 per basic and diluted share, in the first quarter of 2022, up from a net loss of ($1.6) million, or ($0.58) per basic and diluted share, in the first quarter of 2021. In the first quarter of 2022, gross profit was $4.0 million, or 13.2%, compared to gross profit of $1.6 million, or 7.1%, in the first quarter of 2021. Gross profit improvement was primarily due to a combination of higher plant volume and improved operating efficiencies coupled with pricing increases implemented to overcome inflationary cost pressures. First quarter 2022 operating expenses totaled $3.9 million, a 3.7% increase from first quarter 2021 operating expenses of $3.7 million. The increase in operating expenses was primarily driven by $0.3 million in R&D costs in first quarter of 2022 compared to no R&D expense in the first quarter of 2021. First quarter 2022 R&D expense reflects continued investment in new technologies, such as the recently announced AOX cable platform. First quarter 2022 EBITDA, or earnings before interest, taxes, depreciation and amortization, totaled $0.6 million, compared to an EBITDA loss of ($1.5) million in the first quarter of 2021. Business Outlook Mr. Miller stated that "Nortech's results in the first quarter of 2022 are a result of great teamwork with our customers, suppliers and the Nortech team working very closely together to meet our combined goals. In 2022, Nortech will continue this successful collaboration as part of our unique fulfillment solution strategy to overcome component shortages, increase plant throughput, and deliver high quality, mission-critical parts as quickly as possible." Mr. Miller concluded that "We are also focused on generating growth from our newly announced AOX technology. Innovation is a key component of our growth strategy and we are confident that new product technologies will help lay the groundwork for future revenue opportunities that complement our core business." Conference Call Nortech will hold a live conference call and webcast at 4:00 p.m. central time on Wednesday, May 11, 2022, to discuss the company's first quarter financial results. The call will be hosted by Jay D. Miller, Chief Executive Officer and Chris Jones, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 773256. Participants may also access the call via webcast at: https://www.webcaster4.com/Webcast/Page/2814/45283 About Nortech Systems Incorporated Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech Systems primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech's website is www.nortechsys.com. Forward-Looking Statements This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results or trends in financial results, our ability to adjust pricing to combat inflation, our ability to work with customers and suppliers to overcome supply chain challenges, improving supply chain management, growth due to of new products, technologies and innovations, backlog trends, customer demand, the ability of our supply chain to supply materials on a timely basis, and steady improvement in production output. While this release is based on management's best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) engineering challenges with new products, technologies and innovations; (2) our ability to secure intellectual property rights with respect to new products, technologies, and innovations; (3) the impact of the COVID-19 pandemic on our customers, employees, manufacturing facilities, suppliers, the capital markets, and our financial condition; (4) supply chain disruptions leading to parts shortages for critical components; (5) volatility in market conditions which may affect market supply of and demand for the company's products; (6) increased competition; (7) changes in the reliability and efficiency of operating facilities or those of third parties; (8) risks related to the availability of labor; (9) commodity cost increases coupled with our inability to raise prices charged to our customers; (10) general economic, financial, and business conditions that could affect the company's financial condition and results of operations; (11) the Company's ability to steadily improve manufacturing output throughout the remainder of 2022. Some of the above-mentioned factors are described in further detail in the section entitled "Risk Factors" in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. Reconciliation of Non-GAAP Financial Measure EBITDA is a non-GAAP financial measure. EBITDA is defined as net income (loss) plus interest expense, net, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. It is not a measurement of our financial performance under GAAP and should not be considered as alternatives to revenue or net income, as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA has limitations as an analytical tool and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP. EBITDA does not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of ongoing operations and other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510006355/en/ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
